Healthcare -
Medical - Pharmaceuticals - NASDAQ - US
$ 25.2
-0.119 %
$ 1.26 B
Market Cap
None
P/E
HROWL - COST OF REVENUE
Cost of Revenue HROWL - Harrow Health, Inc. 8.625% Senior Notes due 2026
39.6 M
LAST VALUE
47.52%
2 YEAR CAGR
19.13%
5 YEAR CAGR
0.00%
10 YEAR CAGR